Methods for modulating a drug-related effect or behavior Title: United States Patent: 7,365,050 Inventors: Messing; Robert O.(Foster City, CA), Newton; Philip M.
(San Francisco, CA) Assignee: The Regents of the University of California (Oakland, CA) Appl.
No.: 10/913,697 Filed: August 5,...
A new generation of vaccines Four and a half years ago, Schering-Plough was struggling to deal with declining sales and earnings as well as legal and regulatory challenges.Desperately in need of new direction, it found its saviour in Fred Hassan.
Julia Puppe...
The fight against TB Four and a half years ago, Schering-Plough was struggling to deal with declining sales and earnings as well as legal and regulatory challenges.Desperately in need of new direction, it found its saviour in Fred Hassan.
Julia Puppe...
Brilliant BioPharma Four and a half years ago, Schering-Plough was struggling to deal with declining sales and earnings as well as legal and regulatory challenges.Desperately in need of new direction, it found its saviour in Fred Hassan.
Julia Puppe...
PerkinElmer's Path to Biodiscovery nd medical imaging to drug discovery and analytical sciences, PerkinElmer believes its array of predictive diagnostic and detection technologies, buoyed by several recent acquisitions including Evotec and ViaCell, puts the $1.8-billion...
FDA Approves Lilly Drug For Maintenance of ADHD Indianapolis-based Eli Lilly and Co.(NYSE: LLY) says the Food and Drug Administration has approved Strattera for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
An 18-month...
AMA Calls For Tighter Drug Ad Oversight Prescription Drug Ads Influence Patients, Poll Finds AIDS Foundation Sues Pfizer Over Viagra Ads AMA Wants Moratorium on Consumer Ads for New Prescription Drugs Med School Profs Cauterize Drug Ads Consumer Group...
Can Antibodies Help Cure Cancer? Advances in antibody therapy take a promising new approach to how we treat cancer.Antibody-based therapies are commercially successful largely due to their clinical successes in the treatment of cancer and inflammatory diseases.
Bionovo Reports First Quarter 2008 Financial Results EMERYVILLE, Calif., May 9 PRNewswire-FirstCall Bionovo, Inc.(Nasdaq: BNVI) today announced results for the first quarter of 2008.
Quarter Results The company did not report any revenue for the three months ended March 31, 2008.
Cytopia Announces Novel Anti-Cancer Drug Development Collaboration MELBOURNE, Australia, May 9 /PRNewswire-FirstCall/ -- Cytopia Limited (ASX: CYT) today announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd.This...
Region Doing Poor Job in Cancer Prevention Police say a woman in her 60s has died and several others have fallen ill on a halted Via Rail passenger train in Northern Ontario that was en route from Vancouver to Toronto.OPP Sergeant Lauren Nichols says Ambulances and police...
Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript Halozyme Therapeutics Inc.(HALO) Q1 2008 Earnings Call Executives David Ramsay - CFO Jonathan Lim - President and CEO Gregory Frost - VP and CSO Robert Little - VP and CCO Robert Uhl - Senior Director of Investor Relations Analysts...
Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript Halozyme Therapeutics Inc.(HALO) Q1 2008 Earnings Call Executives David Ramsay - CFO Jonathan Lim - President and CEO Gregory Frost - VP and CSO Robert Little - VP and CCO Robert Uhl - Senior Director of Investor Relations Analysts...
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare NGN Capital leads $12 Million in Series A First Tranche Financing SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ -- NGN Capital announced today the formation of ACT Biotech Inc., a new company dedicated to developing and...
New Class of Drugs Might Treat Many Conditions FRIDAY, May 9 (HealthDay News) -- A new class of drugs called vaptans may be able to treat a wide variety of conditions including painful periods, brain hemorrhage, psychotic disorders and glaucoma, Belgian...
Cytopia announces novel anti-cancer drug development collaboration Cytopia Limitedtoday announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd.This agreement leverages Cytopia's early stage drug discovery pipeline of...
Biovail looks for new 'niche' in market Biovail Corp.founder Eugene Melnyk is questioning the direction the new CEO is taking the Meadowvale-based company.
PRINT Bookmark/Search this post with: Biovail Corp., which earned its reputation by producing well-known...
Bionovo Reports First Quarter 2008 Financial Results EMERYVILLE, Calif., May 9 /PRNewswire-FirstCall/ -- Bionovo, Inc.today announced results for the first quarter of 2008.
Quarter Results The company did not report any revenue for the three months ended March 31, 2008.
Revenues for the...
AstraZeneca seeks anxiety indication for Seroquel XR AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for Seroquel XR (quetiapine fumarate) extended-release tablets to seek approval for the...
PolyMedix receives clearance to initiate phase I clinical study of novel systemic antibiotic compound PolyMedix, Inc.has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ('CTA') for its defensin mimetic antibiotic compound, PMX-30063.This notice of no objection allows for the initiation of...
ALSO NOTED: Novartis buys bigger stake in Alnylam; FDA chastises ZymoGenetics' marketing campaign;and much mor > Novartis has scooped up a bigger share of Alnylam stock.The pharma giant now owns 13.3 percent of the company.
Alnylam release > Curious how the FDA might spend its PDUFA fees?
A new five-year plan shows that FDA...
Cytopia, Cancer Therapeutics collaborate on cancer drug discovery Cytopia Ltd and Cancer Therapeutics CRC Pty Ltd will collaborate on an anti-cancer drug discovery and development project.The agreement leverages Cytopias early stage drug discovery pipeline of kinase inhibitors, a class ...
Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomi CAMBRIDGE, Mass., May 8 /PRNewswire/ -- In response to ever increasing cardiac toxicity found in market drugs, Gwathmey Preclinical Testing Services, Inc.today announced the launch of new Cardionomics(TM) services and the...
Expanded Class Action Lawsuit Filed Against Merck & Co Inc (Lawfuel) -- Labaton Sucharow LLP filed a class action lawsuit on May 5, 2008 in the United States District Court for the District of New Jersey, on behalf of purchasers of the securities of Merck & Co., Inc.('Merck'...
The Canadian Press Business News Budget, Thursday, May 8, 2008 TORONTO, Drug developer Biovail Corp.(TSX:BVF) is shutting down two factories in Puerto Rico as it undergoes a major shift in focus to concentrate on developing treatments for central nervous system disorders.
Biovail, which built...
